Femasys Corporation (FEMY): Market Capitalization-to-Revenue Ratio

Femasys Inc. is attracting leading biomedical experts to develop advanced women's health devices under strict FDA supervision. A steady stream of funds from the implementation of fallopian tube diagnostic systems supports liquidity, and the GURU.Markets platform presents this price-to-sales ratio, where 5.10 captures the current value of the indicator. The company delegates a portion of production and global component logistics to external contractors.

Price-to-Revenue Ratio: Femasys (FEMY) for 07/04/2022 - 11/13/2026

Metric breakdowns and analytics for Femasys Corp (FEMY)

- stock quotes and analyst forecast:

Price femasys.com|FEMY - Price Target Chart

- stock exchange capitalization data:

Market Value Femasys Corp|FEMY - Real Price to Acquire Entire Company

- book capitalization indicators:

Book Value per Share Femasys|FEMY - Company Book Value|Market Cap to Net Assets Ratio femasys.com|FEMY - Company Total Assets

- business debt structure and liquidity details:

- company profitability and valuation multiples indicators:

FEMY - Net Profit|Expected Net Profit Femasys Inc.|FEMY - Price to Earnings Ratio|Projected Price to Earnings Femasys Inc|FEMY - PEG Multiple|EV/EBITDA Multiple Femasys Corp|FEMY - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Femasys|FEMY - Net earnings per share for the last 12 months|Earnings per share growth in annualized terms for the last twelve months femasys.com|FEMY - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Femasys Inc.

- total revenue and sales volume data:

FEMY - Company Sales|Company Future Revenue femasys.com|FEMY - P/S Multiple|Market Cap to Expected Sales Ratio Femasys Corp

Summary company analytics:femasys.com

Femasys Inc. is scaling high-tech gynecological solutions where R&D costs precede the mass implementation stage. This P/S chart allows for a comparison of market capitalization against current sales volume, revealing the extent of the premium paid for future earnings. This ratio measures the cost of one dollar of revenue, reflecting market expectations regarding expansion rates. Low variable production costs make this indicator key to assessing the potential for explosive profit growth.

Competitors of Femasys Inc.